Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract
Yun-Yan Sun, Shiwen Peng, Liping Han, et al.
BMC Cancer
|
May 8, 2020
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
Ruey-Shyang Soong, Ravi K Anchoori, Richard B S Roden, et al.
Cell & Bioscience
|
February 27, 2016
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Shiwen Peng, Jin Qiu, Andrew Yang, et al.
Clinical and Experimental Rheumatology
|
June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease
Ami A Shah, Antony Rosen, Laura K Hummers, et al.
Plos Pathogens
|
January 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis
Margaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng, et al.
Plos One
|
January 7, 2015
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer
Shiwen Peng, Joshua W Wang, Balasubramanyam Karanam, et al.
The American Journal of Surgical Pathology
|
January 31, 2025
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva
Guy A Williams, Annie A Wu, Henrietta C Eugene, et al.
Vaccine
|
August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
Kirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Plos One
|
June 14, 2023
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, et al.
Virology
|
May 12, 2005
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
Diana V Pastrana, Ratish Gambhira, Christopher B Buck, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2015
Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract
Yun-Yan Sun, Shiwen Peng, Liping Han, et al.
BMC Cancer
|
May 8, 2020
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
Ruey-Shyang Soong, Ravi K Anchoori, Richard B S Roden, et al.
Cell & Bioscience
|
February 27, 2016
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Shiwen Peng, Jin Qiu, Andrew Yang, et al.
Clinical and Experimental Rheumatology
|
June 20, 2017
Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease
Ami A Shah, Antony Rosen, Laura K Hummers, et al.
Plos Pathogens
|
January 15, 2025
MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis
Margaret Wong, Hsin-Fang Tu, Ssu-Hsieh Tseng, et al.
Plos One
|
January 7, 2015
Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer
Shiwen Peng, Joshua W Wang, Balasubramanyam Karanam, et al.
The American Journal of Surgical Pathology
|
January 31, 2025
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva
Guy A Williams, Annie A Wu, Henrietta C Eugene, et al.
Vaccine
|
August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
Kirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Plos One
|
June 14, 2023
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, et al.
Virology
|
May 12, 2005
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
Diana V Pastrana, Ratish Gambhira, Christopher B Buck, et al.
Page
of 14